{
  "abstract": "The early days of life present clinicians with a paradox. On the one hand, sepsis remains a leading cause of morbidity and mortality among newborns, demanding rapid initiation of antibiotics. On the other hand, the majority of neonates who receive antibiotics for suspected early-onset sepsis (EOS) are ultimately not infected. This tension between the need to protect infants from life-threatening infection and the imperative to avoid unnecessary exposure lies at the heart of neonatal antibiotic stewardship.",
  "authors": [
    {
      "affiliations": [
        "Clinic of Neonatology, Department Mother-Woman-Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland"
      ],
      "name": "Eric Giannoni"
    }
  ],
  "title": "Reducing antibiotic exposure in early life: how low can we go?",
  "uid": "944c019e-525a-505b-9b80-dee9239724b5"
}